LABORATORIOS FARMACEUTICOS ROVI S.A (ROVI.MC)

Every figure this model derived for ROVI.MC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 59,119,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2024-12-31
cash 27,186,000 CashAndCashEquivalents 2025-01-01
current assets 489,606,000 CurrentAssets 2025-01-01
current liabilities 156,651,000 CurrentLiabilities 2025-01-01
equity 572,028,000 EquityAttributableToOwnersOfParent 2025-01-01
interest expense 2,350,000 FinanceCosts 2024-12-31
ocf 138,278,000 CashFlowsFromUsedInOperatingActivities 2024-12-31
revenue 763,749,000 Revenue 2024-12-31
sbc 0 AdjustmentsForSharebasedPayments 2022-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up ROVI.MC on one particular measure came for.

RatioValue
cash operating margin23.51
current ratio3.13
current ratio reported3.13
fcf margin10.36
interest cover76.4
net debt ebitda0.35
operating margin23.51
owner earnings margin10.36
revenue growth-7.93
revenue growth per share-7.93
roic22.32
rule of 4015.58
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about ROVI.MC's figures. Written by the derivation as it ran, not added afterwards.